This site is intended for healthcare professionals
News

FDA approvesTecentriq as a first-line monotherapy for certain people with metastatic non-small cell lung cancer.- Genentech/Roche

Read time: 1 mins
Last updated:21th May 2020
Published:20th May 2020
Condition: Non Small Cell Lung Cancer
Type: drug
Register for free exclusive healthcare eLearning resources


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest